Sign in
Trends in the treatment of proliferative diabetic retinopathy before and after the Diabetic Retinopathy Clinical Research Network Protocol S study
John W Hinkle, MD
Updates from the Field
2020
Masked Safety Data from ZETA-1, an Ongoing 24-Week Phase 2 Clinical Trial of APX3330, an Oral Therapeutic Being Developed for the Treatment of Diabetic Retinopathy
Michael J Allingham, MD, PhD
Annual Meeting Talks
2022
Suprachoroidal Delivery of RGX-314 for Neovascular AMD: Initial Results From the Phase II AAVIATE Study
Mark R. Barakat, MD
2021
Category: Age-Related Macular Degeneration